Biography
Pieter van Baal is a Professor of Public Health Economics. His research focuses on the methodology of cost effectiveness analyses, modeling of diseases/population health and the relation thereof with (non)medical consumption. He has extensive experience in economic evaluations of public health interventions, Markov modeling, uncertainty analyses and is the main developer of PAID (Practical Application to Include future Disease costs).
Pieter has served on the editorial boards of PLoS One, Population Health Metrics and currently is an associate editor of Value of Health.
Researcher
- p.vanbaal@erasmusmc.nl
Erasmus School of Health Policy & Management
Full professor | Health Economics (HE)
- vanbaal@eshpm.eur.nl
More information
Work
- Diederik Brokkelkamp, Vivian Reckers-Droog, Lonneke Timmers & Pieter van Baal (2026) - Use and Outcomes of Cost-Effectiveness Analyses and Additional Considerations in Pharmaceutical Reimbursement in the Netherlands - PharmacoEconomics - doi: 10.1007/s40273-026-01637-w - [link]
- Nilmini Wijemunige, Pieter van Baal, Ravindra P. Rannan-Eliya & Owen O'Donnell (2026) - Dominance-Based Distributional Cost-Effectiveness Analysis of Cardiovascular Disease Risk Screening in Sri Lanka - Value in Health, 29 (6), 1012-1020 - doi: 10.1016/j.jval.2025.09.3062 - [link]
- Michelle C. Turner, Xavier Basagaña, Alex Burdorf, , Irina Guseva Canu, Alexander Gorny, Henrik A. Kolstad, Karin Broberg, Anjoeka Pronk, Jenny Selander, Ingrid Sivesind Mehlum, Pieter van Baal, Sara Svensson, Neil Pearce, Bernice Scholten, Lode Godderis, Kurt Straif, Manosij Ghosh, Susana Viegas, Maria Albin, Jordi Julvez, Joana Porcel & Manolis Kogevinas (2026) - Interventions to promote mental and physical health in changing working environments due to climate change, sustainable work practices, and work in green jobs: The EU INTERCAMBIO project - Journal of Climate Change and Health, 28 - doi: 10.1016/j.joclim.2025.100620 - [link]
- Hamraz Mokri, Pieter van Baal & Maureen Rutten van Mölken (2025) - Lifetime Healthcare and Long-Term Care Costs of Heart Failure: Estimates Using Administrative Data from Hospitalized Patients in the Netherlands - PharmacoEconomics, 43 (11), 1339-1351 - doi: 10.1007/s40273-025-01533-9 - [link]
- Elena Milkovska, Bram Wouterse, Jawa Issa & Pieter Van Baal (2025) - Quantifying the health burden of COVID-19 using individual estimates of years of life lost based on population-wide administrative level data - Epidemiology, 36 (4), 520-530 - doi: 10.1097/ede.0000000000001854 - [link]
- Linda M. de Vries, Werner B.F. Brouwer & Pieter H.M. van Baal (2025) - Benefits beyond health in the willingness to pay for a quality-adjusted life-year - European Journal of Health Economics, 26 (4), 653-670 - doi: 10.1007/s10198-024-01726-7 - [link]
- Nancy J. Devlin, C. Daniel Mullins & Pieter van Baal (2025) - What Does ‘Whole Health’ Really Mean for Health Economics and Outcomes Research? - Value in Health, 28 (5), 699-701 - doi: 10.1016/j.jval.2025.03.006 - [link]
- Saskia de Groot, Hedwig M. Blommestein, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Pieter H.M. van Baal (2025) - Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma - Medical Decision Making, 45 (3), 302-317 - doi: 10.1177/0272989X251319338 - [link]
- Hamraz Mokri, Pieter van Baal & Maureen Rutten-van Mölken (2025) - The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries - European Journal of Health Economics, 26 (1), 71-85 - doi: 10.1007/s10198-024-01690-2 - [link]
- Ting Zhao, Michelle Tew, Talitha Feenstra, Pieter van Baal, Michael Willis, William J. Valentine, Philip M. Clarke, Barnaby Hunt, James Altunkaya, An Tran-Duy, Richard F. Pollock, Samuel J.P. Malkin, Andreas Nilsson, Phil McEwan, Volker Foos, Jose Leal, Elbert S. Huang, Neda Laiteerapong, Mark Lamotte, Harry Smolen, Jianchao Quan, Luís Martins, Mafalda Ramos & Andrew J. Palmer (2024) - The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes - Applied Health Economics and Health Policy, 22 (6), 861-869 - doi: 10.1007/s40258-024-00914-z - [link]
ISPOR
- Start date approval
- July 2026
- End date approval
- April 2028
- Place
- USA
- Description
- Member editorial board Value in Health
Public Health Economics
- Year Level
- master, master, master
- Year
- 2026
- Course Code
- GW4566M
